Adverse Event Initiatives Aim For Better Data, Easier Reporting
This article was originally published in The Silver Sheet
Executive SummaryDEVICE ADVERSE EVENT REPORTING is gradually becoming less burdensome and more standardized as the result of initiatives at FDA and internationally. The MedSun program for a small subset of hospitals is well on its way toward eventually replacing universal user reporting of adverse events, with FDA officials saying the system is providing high quality information that can help manufacturers better understand problems that health care practitioners encounter with their products. Meanwhile, the Global Harmonization Task Force anticipates greater ease for industry in reporting adverse events to international regulatory bodies under its comprehensive reporting guidance, now nearly complete. National regulatory authorities, in turn, will find their job of sharing event data with one another simpler under a new coding system developed by ISO Technical Committee 210
You may also be interested in...
Royal Philips is planning to sell its domestic appliance business to better focus on its strategic aims in health technology. The group made the announcement as it unveiled 2019 sales up 4.5% on a comparable basis.
With just under 120 days until the full application of the EU’s Medical Device Regulation, and fears growing of the loss of products seen as non-compliant, the EU medtech industry has identified a way of broadening the application of the “grace period.” It is a legal way of addressing the potential loss of tens of thousands of products come 26 May, says MedTech Europe’s Oliver Bisazza.
Denmark is moving to a QALY based evaluation system for hospital drugs. Despite a more complex process, the change could still mean quicker market access, says the pharmaceutical industry.